Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Stevens

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
The American Journal of Cardiology|May 30, 2016
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial FibrillationVictoria Jacobs, Heidi T May, Tami L Bair, et al.
Chest|March 8, 2024
Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021Scott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|February 6, 2018
Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery PatientsAnne R Bass, Jackie D Szymonifka, Matthew T Rondina, et al.
Transplantation Direct|March 6, 2023
Performance of a Prospective Anticoagulation Stratification Algorithm After Liver TransplantationJorge Sanchez-Garcia, Fidel Lopez-Verdugo, Spencer LeCorchick, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 18, 2014
Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolismScott C Woller, Scott M Stevens, Steven Towner, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 15, 2015
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)Scott C Woller, Scott M Stevens, David A Kaplan, et al.
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.
American Heart Journal|June 5, 2017
Atrial fibrillation incrementally increases dementia risk across all CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc strata in patients receiving long-term warfarinKevin G Graves, Heidi T May, Victoria Jacobs, et al.
Circulation|April 15, 2009
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsGregory Piazza, Erin J Rosenbaum, William Pendergast, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|May 30, 2016
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial FibrillationVictoria Jacobs, Heidi T May, Tami L Bair, et al.
Chest|March 8, 2024
Antithrombotic Therapy for VTE Disease: Compendium and Review of CHEST Guidelines 2012-2021Scott M Stevens, Scott C Woller, Lisa Baumann Kreuziger, et al.
HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery|February 6, 2018
Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery PatientsAnne R Bass, Jackie D Szymonifka, Matthew T Rondina, et al.
Transplantation Direct|March 6, 2023
Performance of a Prospective Anticoagulation Stratification Algorithm After Liver TransplantationJorge Sanchez-Garcia, Fidel Lopez-Verdugo, Spencer LeCorchick, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 18, 2014
Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolismScott C Woller, Scott M Stevens, Steven Towner, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 15, 2015
Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS)Scott C Woller, Scott M Stevens, David A Kaplan, et al.
The American Journal of Cardiology|May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial FibrillationAnjani Golive, Heidi T May, Tami L Bair, et al.
Journal of Cardiovascular Electrophysiology|August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of DementiaVictoria Jacobs, Scott C Woller, Scott M Stevens, et al.
American Heart Journal|June 5, 2017
Atrial fibrillation incrementally increases dementia risk across all CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc strata in patients receiving long-term warfarinKevin G Graves, Heidi T May, Victoria Jacobs, et al.
Circulation|April 15, 2009
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsGregory Piazza, Erin J Rosenbaum, William Pendergast, et al.
Pageof 11